Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 71OTHER_GOV 7INDUSTRY 7UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 58Breast 49Thoracic 24Head & Neck 13Lymphoid 12CNS 6Other hematologic neoplasm 5Gynecologic 5Tumor-Agnostic 3Sarcoma 3Other solid neoplasm 2Genitourinary 2Other neoplasm 1NET 1Myeloid 1Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1

Interventions

Thalidomide 1Temozolomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × NET × Clear all
NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown
60 enrolled
EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡